Register your Account

Sign Up with us and Enjoy!
User name Email First Name Last Name Contact info

A password will be e-mailed to you.

 
 
 

Gainers To Watch – MCP, LXK, KEP, HDB, RAS


NEW YORK, January 15, 2013, (MESHPRESS) – Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following Tuesday’s Top Gainers:-

Molycorp Inc (NYSE:MCP) stock climbed 3.54% to $8.78. The company, on Jan. 10, announced that all key production components of its new state-of-the-art rare earth manufacturing complex in Mountain Pass, California are up and operational and that the facility has begun ramping up to its full-scale “Phase 1″ run rate.

Additionally, Equities researchers at JPMorgan Chase dropped their target price on shares of Molycorp from $8.00 to $5.00 in a report issued on Jan. 10. The firm currently has an “underweight” rating on the stock.

Can MCP Continue To Move Higher? Find Out Here

Lexmark International Inc (NYSE:LXK) shares jumped 3.43% and closed at $26.85. The company, on Jan. 2, announced the acquisition of Acuo Technologies, LLC, a recognized leader in high performance software and services for clinical content management, data migration and vendor neutral archives (VNA), for a cash purchase price of approximately $45 million. Acuo Technologies will become a part of Perceptive Software, a Lexmark company.

Can LXK Extend Rally? Find Out Here 

Korea Electric Power Corporation (ADR) (NYSE:KEP) shares increased 3.42% to $16.35. The company, on Dec. 17, announced that it has appointed Cho Hwan Yin as its new Chief Executive Officer, replacing Cho Yin Guk, effective December 17, 2012. The company is a Korea-based company engaged in the generation, transmission and distribution of electricity and development of electric power resources in the Republic of Korea.

How Should Investors Trade KEP Now? Find Out Here

HDFC Bank Limited (ADR) (NYSE:HDB) shares climbed 3.24% to $42.05 in the previous trading session. The 52 week trading range for the company is $27.30 – $43.02. The shares of the company gained 50% in the last one year. The company is a banking company engaged in providing a range of banking and financial services, including commercial banking and treasury operations.

How Should Investors React To HDB Now? Find Out Here

RAIT Financial Trust (NYSE:RAS) shares increased 4.92% to $6.40. The company, on Jan. 10, said it will begin trading ex-dividend on January 14, 2013. A cash dividend payment of $0.1 per share is scheduled to be paid on January 31, 2013. Shareholders who purchased RAS stock prior to the ex-dividend date are eligible for the cash dividend payment.

How Should Investors React To RAS Now? Find Out Here

About Csrnewsdaily.com

Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer:

The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:

Csrnewsdaily.com

info@csrnewsdaily.com

font-f�y”�>h�’ Roman”;color:#444444′>Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

 

Disclaimer:

The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:

Csrnewsdaily.com

info@csrnewsdaily.com

 

Related Press realease: